Effects of antiparkinson medication on cognition in Parkinson's disease: a systematic review
MA Roy, M Doiron, J Talon-Croteau… - Canadian Journal of …, 2018 - cambridge.org
Objective: This study aimed to systematically review the effects of currently prescribed
antiparkinson medication on cognition in patients with mild-to-moderate Parkinson's disease …
antiparkinson medication on cognition in patients with mild-to-moderate Parkinson's disease …
Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease
Introduction To investigate the relationship between the sub-regional pattern of striatal
dopamine depletion and cognitive impairment in early-stage Parkinson's disease (PD), and …
dopamine depletion and cognitive impairment in early-stage Parkinson's disease (PD), and …
Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures
SL Flannery, T Jowett, A Garvey… - Journal of clinical and …, 2018 - Taylor & Francis
Objective: This study assessed deficits associated with Parkinson's disease (PD) at two time
points separated by 1 year using a computerized neuropsychological battery, and …
points separated by 1 year using a computerized neuropsychological battery, and …
Neuropsychiatry
J Hindle - Parkinson's disease in the older patient, 2018 - taylorfrancis.com
Parkinson's disease (PD) is a complex disorder with neurological and psychiatric
components. The maintenance of mental health in PD may be more important than the …
components. The maintenance of mental health in PD may be more important than the …
Características neuropsicológicas de pacientes con enfermedad de Parkinson sin demencia
VA López Cortés - 2018 - gredos.usal.es
[ES] Introducción: La Enfermedad de Parkinson (EP) es una enfermedad neurodegenerativa
causada por la pérdida selectiva de neuronas dopaminérgicas de la sustancia negra pars …
causada por la pérdida selectiva de neuronas dopaminérgicas de la sustancia negra pars …